Literature DB >> 25131580

Enhanced RBC Aggregation in Type 2 Diabetes Patients.

Qing Li1, Li Li2, Yong Li1.   

Abstract

BACKGROUND: This study aimed to investigate the relationship between HbA1c and RBC aggregation in type 2 diabetes mellitus (T2DM) patients by analysis of data from routine clinical tests and from in vitro experiments.
METHODS: A total of 2,111 inpatients with type 2 diabetes were selected and among them, 364 patients (Group A) had limited influence of plasma proteins on erythrocyte sedimentation rate (ESR) and was compared with the rest of the 1,747 inpatients (Group B). ESR, HbA1c , WBC, CRP, Fbg, and HCT were measured in all samples. Sixty samples were also collected from T2DM patients and used for in vitro ESR studies. Spearman's correlation coefficients were employed to reflect the correlation between ESR and other parameters. Mann-Whitney U test was used to compare the study parameters.
RESULTS: The test results for Group A were lower than Group B with respect to ESR, age, HCT, HbA1c , CRP, WBC, and Fbg. Only the difference in HbA1c , CRP, and Fbg values had statistical significance (P < 0.05). In addition, HbA1c correlated better with ESR for Group A (R = 0.622) than Group B (R = 0.563), whereas CRP and Fbg were contrary to this. In the in vitro studies, the HbA1c values were classified into the subgroups of 6.5-8.0%, 8.1-10%, and >10%. The corresponding ESR values were 28 ± 5.1 mm/h, 33 ± 2.7 mm/h, and 40 ± 4.1 mm/h, respectively.
CONCLUSION: ESR results of T2DM patients were elevated that was mainly caused by Fbg levels, and in addition HbA1c in part contributed to RBC aggregation.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  HbA1c; RBC aggregation; T2DM; erythrocyte sedimentation rate

Mesh:

Substances:

Year:  2014        PMID: 25131580      PMCID: PMC6806712          DOI: 10.1002/jcla.21784

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  15 in total

1.  Decreased red blood cell aggregation subsequent to improved glycaemic control in Type 2 diabetes mellitus.

Authors:  B Chong-Martinez; T A Buchanan; R B Wenby; H J Meiselman
Journal:  Diabet Med       Date:  2003-04       Impact factor: 4.359

2.  Increased red cell aggregation is correlated with HbA1C and lipid levels in type 1 but not type 2 diabetes.

Authors:  D Zilberman-Kravits; I Harman-Boehm; T Shuster; N Meyerstein
Journal:  Clin Hemorheol Microcirc       Date:  2006       Impact factor: 2.375

3.  Red blood cell aggregation in diabetes mellitus.

Authors:  C Le Devehat; M Vimeux; G Bondoux; T Khodabandehlou
Journal:  Int Angiol       Date:  1990 Jan-Mar       Impact factor: 2.789

4.  Erythrocyte sedimentation rate in diabetic patients: relationship to glycosylated hemoglobin and serum proteins.

Authors:  A N Elias; E Domurat
Journal:  J Med       Date:  1989

5.  Effect of atorvastatin on hemorheologic-hemostatic parameters and serum fibrinogen levels in hyperlipidemic patients.

Authors:  C A Dujovne; W S Harris; R Altman; R W Overhiser; D M Black
Journal:  Am J Cardiol       Date:  2000-02-01       Impact factor: 2.778

6.  Enhanced erythrocyte aggregation in type 2 diabetes with late complications.

Authors:  H Demiroglu; A Gürlek; I Barişta
Journal:  Exp Clin Endocrinol Diabetes       Date:  1999       Impact factor: 2.949

7.  Rheological determinants of red blood cell aggregation in diabetic patients in relation to their metabolic control.

Authors:  K Elishkevitz; R Fusman; M Koffler; I Shapira; D Zeltser; D Avitzour; N Arber; S Berliner; R Rotstein
Journal:  Diabet Med       Date:  2002-02       Impact factor: 4.359

8.  Markers of inflammation in patients with coronary artery disease are also associated with glycosylated haemoglobin A1c within the normal range.

Authors:  Carl Gunnar Gustavsson; Carl-David Agardh
Journal:  Eur Heart J       Date:  2004-12       Impact factor: 29.983

9.  Inflammatory activity increases with haemoglobin A1c in patients with acute coronary syndrome.

Authors:  Carl Gunnar Gustavsson; Carl-David Agardh
Journal:  Scand Cardiovasc J       Date:  2009-12       Impact factor: 1.589

10.  Red blood cell aging and risk of cardiovascular diseases.

Authors:  M V Kameneva; K O Garrett; M J Watach; H S Borovetz
Journal:  Clin Hemorheol Microcirc       Date:  1998-04       Impact factor: 2.375

View more
  5 in total

1.  Simultaneous assessment of red blood cell aggregation and oxygen saturation under pulsatile flow using high-frequency photoacoustics.

Authors:  Tae-Hoon Bok; Eno Hysi; Michael C Kolios
Journal:  Biomed Opt Express       Date:  2016-06-23       Impact factor: 3.732

2.  Effect of diabetic duration on hemorheological properties and platelet aggregation in streptozotocin-induced diabetic rats.

Authors:  Eunseop Yeom; Hyeokjun Byeon; Sang Joon Lee
Journal:  Sci Rep       Date:  2016-02-22       Impact factor: 4.379

Review 3.  Potential Diagnostic Hemorheological Indexes for Chronic Kidney Disease in Patients With Type 2 Diabetes.

Authors:  Hoyoon Lee; Wonwhi Na; Sang Bae Lee; Chul Woo Ahn; Jun Sung Moon; Kyu Chang Won; Sehyun Shin
Journal:  Front Physiol       Date:  2019-08-20       Impact factor: 4.566

4.  Multimodal Diagnostics of Microrheologic Alterations in Blood of Coronary Heart Disease and Diabetic Patients.

Authors:  Anastasia Maslianitsyna; Petr Ermolinskiy; Andrei Lugovtsov; Alexandra Pigurenko; Maria Sasonko; Yury Gurfinkel; Alexander Priezzhev
Journal:  Diagnostics (Basel)       Date:  2021-01-06

5.  Microfluidics Approach to the Mechanical Properties of Red Blood Cell Membrane and Their Effect on Blood Rheology.

Authors:  Claudia Trejo-Soto; Guillermo R Lázaro; Ignacio Pagonabarraga; Aurora Hernández-Machado
Journal:  Membranes (Basel)       Date:  2022-02-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.